Abstract
Polyol synthesis is a promising method to obtain directly pharmaceutical grade colloidal dispersion of superparamagnetic iron oxide nanoparticles (SPIONs). Here, we study the biocompatibility and performance as T2-MRI contrast agents (CAs) of high quality magnetic colloidal dispersions (average hydrodynamic aggregate diameter of 16-27 nm) consisting of polyol-synthesized SPIONs (5 nm in mean particle size) coated with triethylene glycol (TEG) chains (TEG-SPIONs), which were subsequently functionalized to carboxyl-terminated meso-2-3-dimercaptosuccinic acid (DMSA) coated-iron oxide nanoparticles (DMSA-SPIONs). Standard MTT assays on HeLa, U87MG, and HepG2 cells revealed that colloidal dispersions of TEG-coated iron oxide nanoparticles did not induce any loss of cell viability after 3 days incubation with dose concentrations below 50 μg Fe/ml. However, after these nanoparticles were functionalized with DMSA molecules, an increase on their cytotoxicity was observed, so that particles bearing free terminal carboxyl groups on their surface were not cytotoxic only at low concentrations (<10 μg Fe/ml). Moreover, cell uptake assays on HeLa and U87MG and hemolysis tests have demonstrated that TEG-SPIONs and DMSA-SPIONs were well internalized by the cells and did not induce any adverse effect on the red blood cells at the tested concentrations. Finally, in vitro relaxivity measurements and post mortem MRI studies in mice indicated that both types of coated-iron oxide nanoparticles produced higher negative T2-MRI contrast enhancement than that measured for a similar commercial T2-MRI CAs consisting in dextran-coated ultra-small iron oxide nanoparticles (Ferumoxtran-10). In conclusion, the above attributes make both types of as synthesized coated-iron oxide nanoparticles, but especially DMSA-SPIONs, promising candidates as T2-MRI CAs for nanoparticle-enhanced MRI diagnosis applications.
Similar content being viewed by others
Notes
Commercial dispersion of dextran-coated ultra-small iron oxide nanoparticles (Ferumoxtran-10) was obtained from Guerbet Group S.A. (Roissy, France) via a scientific collaborative agreement with the Department de Bioquímica I Biología Molecular of the Universitat Autònoma de Barcelona.
References
Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y, Yuh WT, Runge VM, Morris MR, McLachlan SJ, Lufkin RB (1994) Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 192:709–715
Bomati-Miguel O, Gossuin Y, Morales MP, Gillis P, Muller RN (2007) Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core–shell iron–iron oxide nanoparticles. Magn Reson Imaging 25:1437–1441
Cañete M, Soriano J, Villanueva A, Roca AG, Veintemillas S, Serna CJ, Miranda R, Morales MP (2010) The endocytic penetration mechanism of iron oxide magnetic nanoparticles with positively charged cover: a morphological approach. Int J Mol Med 26:533–539
Caravan P (2009) Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res 42:851–862
Coleman J, Nascimiento R, Solomon SB (2007) Advances in imaging for urologic procedures. Nat Clin Pract Urol 4:498–504
Corot C, Robert P, Idée JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58(14):1471–1504
Figuerola A, Di Corato R, Manna L, Pellegrino T (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharm Res 62(2):126–143
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577–5591
Gossuin Y, Gillis P, Hocq A, Vuong Q, Roch A (2009) Magnetic resonance relaxation properties of superparamagnetic particles. Wires Nanomed Nanobiotechnol 1(3):299–310
Groman EV, Bouchard JC, Reinhardt CP, Vaccaro DE (2007) Ultrasmall mixed ferrite colloids as multidimensional magnetic resonance imaging, cell labeling, and cell sorting agents. Bioconjug Chem 18:1763–1771
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021
Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM (2011) Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives. Anal Bioanal Chem 399:3–27
Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR (1999) MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic–pathologic correlation. AJR Am J Roentgenol 172:1347–1351
Huang J, Zhong X, Wang L, Yang L, Mao H (2012) Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics 2(1):86–102
Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Mag Reson Imaging 13(5):661–674
Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ (2001) Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 14:595–601
Kriege M et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437
Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110
Maity D, Kale SN, Kaul-Ghanekar R, Xue JM, Ding J (2009) Studies of magnetite nanoparticles synthesized by thermal decomposition of iron(III) acetylacetonate in tri(ethyleneglycol). J Magn Magn Mater 321:3093–3098
Maity D, Chandrasekharan P, Yang CT, Chuang KH, Shuter B, Xue JM, Ding J, Feng SS (2010) Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications. Nanomedicine 5(10):1571–1584
McDermott S, Guimaraes AR (2012) Magnetic nanoparticles in the imaging of tumor angiogenesis. Appl Sci 2(2):525–534
Miguel-Sancho M, Bomati-Miguel O, Colom G, Pablo-Salvador J, Marco MP, Santamaría J (2011) Development of stable, water-dispersable, and biofunctionalizable superparamagnetic iron oxide nanoparticles. Chem Mater 23:2795–2802
Miguel-Sancho M, Bomatí-Miguel O, Roca AG, Martínez G, Arruebo M, Santamaría J (2012) Synthesis of magnetic nanocrystals by thermal decomposition in glycol media: effect of process variables and mechanistic study. Ind Eng Chem Res 51:8348–8357
Mondini S, Cenedese S, Marioni G, Molteni G, Santo N, Bianchi CL, Ponti A (2008) One-step synthesis and functionalization of hydroxyl-decorated magnetite nanoparticles. J Colloid Interface Sci 322:173
Monet X, Weissleder R, Josephson L (2006) Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem 17(4):905–911
Morales MP, Bomati-Miguel O, Perez de Alejo R, Ruiz-Cabello J, Veintemillas-Verdaguer S, O’Grady K (2003) Contrast agents for MRI based on iron oxide nanoparticles prepared by laser pyrolysis. J Magn Magn Mater 266:102–109
Pankhurst QA, Thanh NKT, Jones SK, Dobson J (2009) Progress in applications of magnetic nanoparticles in biomedicine. J Phys D 42:224001
Roca AG, Veintemillas-Verdaguer S, Port M, Robic C, Serna CJ, Morales MP (2009) Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. J Phys Chem B 113:7033–7039
Roca AG, Carmona D, Miguel-Sancho N, Bomati-Miguel O, Balas F, Piquer C, Santamaria J (2012) Surface functionalization for tailoring the aggregation and magnetic behaviour of silica-coated iron oxide nanostructures. Nanotechnology 23:155603
Rümenapp C, Gleich B, Haase A (2012) Magnetic nanoparticles in magnetic resonance imaging and diagnostics. Pharm Res 29(5):1165–1179
Sharma P, Brown S, Walter G, Santra S, Moudgil B (2006) Nanoparticles for bioimaging. Adv Colloid Interface Sci 123–126:471–485
Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ (1993) Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29(5):599–604
Sun C, Sze R, Zhang M (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 78(3):550–557
Suzuki H, Tsurita G, Ishihara S, Akahane M, Kitayama J, Nagawa H (2008) Resovist-enhanced MRI for preoperative assessment of colorectal hepatic metastases: a case of multiple bile duct hamartomas associated with colon cancer. Case Rep Gastroenterol 2(3):509–516
Theppaleak T, Tumcharern G, Wichai U, Rutnakornpituk M (2009) Synthesis of water dispersible magnetite nanoparticles in the presence of hydrophilic polymers. Polym Bull 63:79–90
Thorek DLJ, Chen AK, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34(1):23–28
Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Décorps M (2001) Vessel size imaging. Magn Reson Med 45:397–408
Villanueva A, Cañete M, Roca AG, Calero M, Veintemillas-Verdagüer S, Serna CJ, Morales MP, Miranda R (2009) The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 20:115103 (9 pp)
Wan J, Cai W, Meng X, Liu E (2007) Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chem Commun 47:5004–5006
Wei C, Wan J (2007) Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J Colloid Interface Sci 305:366–370
Weinreb JC, Abu-Alpha AK (2009) Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned? J Magn Reson Imaging 30:1236–1239
Weissleder R, Hahn PF, Stark DD, Elizondo G, Saini S, Todd LE, Wittenberg J, Ferruci JT (1998) Superparamagnetic iron oxide: enhanced detection of splenic tumors with MR imaging. Radiology 169:399–403
Wu W, He Q, Jiang C (2008) Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett 3:397–415
Yan GP, Robinson L, Hogg P (2007) Magnetic resonance imaging contrast agents: overview and perspectives. Radiography 13:e5–e19
Yang WJ, Lee JH, Hong SC, Lee J, Lee J, Han DW (2013) Nanoparticles with various surface-functional groups against human normal fibroblast and fibrosarcoma cells. Materials 6:4689–4706
Acknowledgments
This research was supported by ARAID Foundation (Regional Government of Aragon), and “Centro de Investigación Biomédica en Red—Bioingeniería, Biomateriales y Nanomedicina” (CIBER-BBN), through the intramural research projects IMAFEN (2008–2009) NANOMAG (2008–2009), PROGLIO (2010–2011), and PROGLIO2 (2012–2013). OBM thanks the financial support from the “Ramón y Cajal Program” of the Spanish Ministry of Economy and Competitiveness (MINECO). AGR would like to thank the funding of Spanish Ministerio de Educación, through Programa Nacional de Movilidad de Recursos Humanos 2011.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bomati-Miguel, O., Miguel-Sancho, N., Abasolo, I. et al. Ex vivo assessment of polyol coated-iron oxide nanoparticles for MRI diagnosis applications: toxicological and MRI contrast enhancement effects. J Nanopart Res 16, 2292 (2014). https://doi.org/10.1007/s11051-014-2292-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-014-2292-7